Reply to Flugge: the anti-metastatic potential of methionine restriction in melanoma
- PMID: 31140558
- PMCID: PMC7221500
- DOI: 10.1093/carcin/bgz099
Reply to Flugge: the anti-metastatic potential of methionine restriction in melanoma
Comment on
-
Modulation of dietary methionine intake elicits potent, yet distinct, anticancer effects on primary versus metastatic tumors.Carcinogenesis. 2018 Sep 21;39(9):1117-1126. doi: 10.1093/carcin/bgy085. Carcinogenesis. 2018. PMID: 29939201 Free PMC article.
-
The anti-metastatic potential of methionine restriction in melanoma: a reply to Miousse et al. (2018).Carcinogenesis. 2020 May 14;41(3):392-393. doi: 10.1093/carcin/bgz097. Carcinogenesis. 2020. PMID: 31188424 No abstract available.
References
-
- Fluegge K. (2019) The anti-metastatic potential of methionine restriction in melanoma: a reply to Miousse et al. (2018). - PubMed
-
- Chello P.L., et al. (1973) Dependence of 5-methyltetrahydrofolate utilization by L5178Y murine leukemia cells in vitro on the presence of hydroxycobalamin and transcobalamin II. Cancer Res., 33, 1898–1904. - PubMed
-
- Liteplo R.G. (1989) Altered methionine metabolism in metastatic variants of a human melanoma cell line. Cancer Lett., 44, 23–31. - PubMed
-
- Loewy A.D., et al. (2009) Epigenetic modification of the gene for the vitamin B(12) chaperone MMACHC can result in increased tumorigenicity and methionine dependence. Mol. Genet. Metab., 96, 261–267. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical